Two-decade analysis of cardiac storage for transplantation

European Journal of Cardio-thoracic Surgery

Volumn 20, Issue 4, 2001, Pages 792-798

  Stoica, Serban C ^a   Satchithananda, Duwarakan K ^a   Dunning, John ^a   Large, Stephen R ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Cardiac transplantation; Endothelium; Myocardium; Preservation; Storage

Indexed keywords

CARDIOPLEGIC AGENT;

ANIMAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DONOR; HEART MUSCLE; HEART TRANSPLANTATION; HUMAN; META ANALYSIS; METHODOLOGY; ORGAN PRESERVATION; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; TIME; TREATMENT OUTCOME;

ANIMALS; CARDIOPLEGIC SOLUTIONS; HEART TRANSPLANTATION; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGAN PRESERVATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; TISSUE DONORS;

EID: 0035489996     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(01)00847-8     Document Type: Review

References (61)

1. Hearse DJ, Humphrey SM, Bullock GR. The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol 1978;10:641-668.
2. Billingham ME, Baumgartner WA, Watson DC, Reitz BA, Masek MA, Raney AA, Oyer PE, Stinson EB, Shumway NE. Distant heart procurement for human transplantation - ultrastructural studies. Circulation 1980;62:SI11-SI19.
3. Thomas FT, Szentpetery SS, Mammana RE, Wolfgang TC, Lower RR. Long-distance transportation of human hearts for transplantation. Ann Thor Surg 1978;26:344-350.
4. Darracott-Cankovic S, Wheeldon D, Cory-Pearce R, Wallwork J, English TAH. Biopsy assessment of fifty hearts during transplantation. J Thorac Cardiovasc Surg 1987;93:95-102.
5. Konertz WF, Saka B, Bernhard A. Euro-Collins solution for heart preservation: experimental and clinical experience. Transplant Proc 1988;20:984-986.
6. Stein DG, Drinkwater DC, Laks H, Permut LC, Sangwan S, Chait HI, Child JS, Bhuta S. Cardiac preservation in patients undergoing transplantation. A clinical trial comparing University of Wisconsin solution and Stanford solution. J Thorac Cardiovasc Surg 1991;102:657-665.
7. Mendler N. The meta-physiology of organ preservation. J Heart Lung Transplant 1992;11:8192-8195.
8. Jahania MS, Sanchez JA, Narayan P, Lasley RD, Mentzer RM. Heart preservation for transplantation: principles and strategies. Ann Thorac Surg 1999;68:1983-1987.
9. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302.
10. Menasche P, Termignon JL, Pradier F, Grousset C, Mouas C, Alberici G, Weiss M, Piwnica A, Bloch G. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardio-thorac Surg 1994;8:207-213.
11. Ou R, Gavin JB, Esmore DS, Rosenfeldt FL. Increased temperature reduces the protective effect of University of Wisconsin solution in the heart. Ann Thorac Surg 1999;68:1628-1634.
12. Wildhirt SM, Weis M, Schulze C, Conrad N, Rieder G, Enders G, Ihnken K, von Scheidt W, Reichart B. Effects of Celsior and University of Wisconsin preservation solutions on haemodynamics and endothelial function after cardiac transplantation in humans: a single-center, prospective, randomized trial. Transpl Int 2000;13:8203-8211.
13. Garlicki M, Kolcz J, Rudzinski P, Kapelak B, Sadowski J, Wojcik S, Pietrzyk E, Frasik W, Drukala J, Dziatkowiak A. Myocardial protection for transplantation. Transplant Proc 1999;31:2079-2083.
14. Luciani GB, Faggian G, Montalbano G, Casali G, Forni A, Chiominto B, Mazzucco A. Blood versus crystalloid cardioplegia for myocardial protection of donor hearts during transplantation: a prospective, randomized clinical trial. J Thorac Cardiovasc Surg 1999;118:787-795.
15. Carrier M, Leung TK, Solymoss BC, Cartier R, Leclerl Y, Pelletier LC. Clinical trial of retrograde warm blood reperfusion versus standard cold topical irrigation of transplanted hearts. Ann Thorac Surg 1996;61:1310-1315.
16. Copeland JG, Jones M, Spragg R, Stinson EB. In vitro preservation of canine hearts for 24 to 28 hours followed by successful orthotopic transplantation. Ann Surg 1973;178:687-692.
17. Wheeldon D, Sharples L, Wallwork J, English T. Donor heart preservation survey. J Heart Lung Transplant 1992;11:986-993.
18. Demmy TL, Biddle JS, Bennett LE, Walls JT, Schmaltz RA, Curtis JJ. Organ preservation solutions in heart transplantation - patterns of usage and related survival. Transplantation 1997;63:262-269.
19. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report-1998. J Heart Lung Transplant 1998;17:656-668.
20. Stoica SC, Goddard M, Large SR. The endothelium in clinical cardiac transplantation. Ann Thorac Surg 2001 (in press).
21. Day JD, Rayburn BK, Gaudin PB, Baldwin WM, Lowenstein CJ, Kasper EK, Baughman KL, Baumgartner WA, Hutchins GM, Hruban RH. Cardiac allograft vasculopathy: the central pathogenic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 1995;14:S142-S149.
22. Davis SF, Yeung AC, Meredith IT, Charbonneau F, Ganz P, Selwyn AP, Anderson TJ. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year post-transplant. Circulation 1996;93:457-462.
23. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998;65:1533-1542.
24. Van der Hoeven JAB, Ploeg RJ, Postema F, Molema G, de Vos P, Girbes AR, van Suvlichem PT, Ter Horst GJ. Induction of organ dysfunction and activation of inflammatory markers in donor liver and kidney during hypotensive brain death. Transplant Proc 1999;31:1006-1007.
25. Land W. Postischemic reperfusion injury to allografts: its impact on T-cell alloactivation via upregulation of dendritic cell-mediated stimulation, co-stimulation and adhesion. Curr Opin Organ Transpl 1999(4):118-124.
26. Wang CY, Aronson I, Takuma S, Homma S, Naka Y, Alshafie T, Broykovych V, Malinski T, Oz MC, Pinsky DJ. cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy. Circ Res 2000;86:982-988.
27. Weis M, von Scheidt W. Cardiac allograft vasculopathy. Circulation 1997;96:2069-2077.
28. Hancock WW. Molecular basis of chronic rejection. Curr Opin Organ Transplant 1999;4:3-10.
29. Opelz G, Wujciak MS. The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med 1994;330:816-819.
30. Rosenfeldt FL, Couyers RA, Jablonski P, Langley L, Richards SM, Self G, Marshall V. Comparison of UW solution and St Thomas' solution in the rat: importance of potassium concentration. Ann Thor Surg 1996;61:576-584.
31. Langendorff O. Untersuchungen am uberlebenden Saugethierherzen. Pflugers Arch 1895;61:291-332.
32. Sutherland FJ, Hearse DJ. The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000;41:613-627.
33. Galinanes M, Hearse DJ. The consequences of asanguineous versus sanguineous reperfusion after long-term preservation of the heart. Eur J Cardio-thorac Surg 1990;4:273-277.
34. Tixier D, Matheis G, Buckberg GD, Young HH. Donor hearts with impaired hemodynamics. J Thorac Cardiovasc Surg 1991;102:207-214.
35. Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993;87:230-239.
36. Galinanes M, Hearse DJ. Brain-death-induced cardiac contractile dysfunction: studies of possible neurohormonal and blood-borne mediators. J Moll Cell Cardiol 1994;26:481-488.
37. Chiari P, Hadour G, Michel P, Piriou V, Rodriguez C, Budat C, Ovize M, Jegaden O, Lehot JJ, Ferrera R. Biphasic response after brain death induction: prominent part of catecholamines release in this phenomenon. J Heart Lung Transplant 2000;19:675-682.
38. Szabo G, Hackert T, Sebening C, Melnitchuk S, Vahl CF, Hagl S. role of neural and humoral factors in hyperdynamic reaction and cardiac dysfunction following brain death. J Heart Lung Transplant 2000;19:683-693.
39. Yeh T, Wechsler AS, Graham LJ, Loesser KE, Sica DA, Wolfe L, Jakoi ER. Acute brain death alters left ventricular myocardial gene expression. J Thorac Cardiovasc Surg 1999;117:365-374.
40. Jeevanandam V, Auteri JS, Sanchez JA, Hsu D, Marboe C, Smith CR, Rose EA. Cardiac transplantation after prolonged graft preservation with the University of Wisconsin solution. J Thorac Cardiovasc Surg 1992;104:224-228.
41. Fremes SE, Furukawa RD, Li RK, Weisel RD, Mickle DA, Tumiati LC. Comparison of two experimental models for assessment of cardiac preservation. Ann Thorac Surg 1993;55:144-150.
42. Masuda M, Sukehiro S, Mollhoff T, Lu HR, Van Belle H, Flameng W. Degradation of myocardial high-energy phosphates during twenty-four hours of cold storage. J Thorac Cardiovasc Surg 1992;103:993-1000.
43. Minten J, Segel L, Van Belle H, Wynants J, Flameng W. Differences in high-energy phosphate metabolism between the rat and the dog in a heart preservation model. J Heart Lung Transplant 1991:1071-1078.
44. MacKenna D, Summerour SR, Villarreal FJ. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000;46:257-263.
45. Densem CG, Hutchinson IV Yon, an N, Sheldon S, Brooks NH. A low producing TGF-β allele in the donor or recipient genotype protects from cardiac transplant vasculopathy. J Heart Lung Transplant 2000;19:54.
46. Read MA, Whitley MZ, Williams AJ, Collins T. NF-κB and IκBα-an inducible regulatory system in endothelial activation. J Exp Med 1994;179:503-512.
47. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J Clin Invest 1999;103:543-553.
48. Feeley BT, Park AK, Hoyt G, Robbins RC. Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants. J Heart Lung Transplant 1999;18:1088-1095.
49. Thomas F, Wu J, Thomas JM. Apoptosis and organ transplantation. Curr Opin Organ Transplant 2000;5:35-41.
50. Depre C, Taegtmeyer H. Metabolic aspects of programmed cell survival and cell death in the heart. Cardiovasc Res 2000;45:538-548.
51. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 1997;57:1835-1840.
52. Kirshenbaum L, de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997;96:1580-1585.
53. Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, Douglas JT, Thomas FT, Thomas JM, Curiel DT. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic human bcl-2 gene. Ann Surg 1999;230:185-193.
54. Dong C, Wilson JE, Winters GL, McMannus BM. Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy. Lab Invest 1996;74:921-931.
55. Collard CD, Agah A, Stahl GL. Complement activation following reoxygenation of hypoic human endothelial cells: role of intracellular reactive oxygen species and new protein synthesis. Immunopharmacology 1998;39:39-50.
56. Azzawi M, Hasleton P. Tumour necrosis factor alpha and the cardiovascular system: its role in cardiac allograft rejection and heart disease. Cardiovasc Res 1999;43:850-859.
57. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in ischemia-reperfusion injury. Cardiovasc Res 1999;43:860-878.
58. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 1999;85:753-766.
59. Sack MN, Smith RM, Opie LH. Tumour necrosis factor in myocardial hypertrophy and ischaemia - an anti-apoptotic perspective. Cardiovasc Res 2000;45:688-695.
60. Schett G, Metzler B, Kleindienst R, Amberger A, Recheis H, Xu Q, Wick G. Myocardial injury leads to release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc Res 1999;42:685-695.
61. Birks EJ, Owen VJ, Burton PBJ, Bishop AE, Banner NR, Khaghani A, Polak JM, Yacoub MH. Tumour necrosis factor-α is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000;102:326-331.